antibodies, antiphospholipid

Therapy with direct oral anticoagulants for secondary prevention of thromboembolic events in the antiphospholipid syndrome: a systematic review and meta-analysis of randomised trials
Josefine B H Adelhelm, Robin Christensen, Gustavo G M Balbi, Anne Voss

Lupus Science & Medicine Oct 2023, 10 (2) e001018; DOI: 10.1136/lupus-2023-001018
Risk factors of disease flares in a Chinese lupus cohort with low-grade disease activity
Fangfang Sun, Liling Zhao, Haiting Wang, Danting Zhang, Jie Chen, Xiaodong Wang, Ting Li, Shuang Ye

Lupus Science & Medicine May 2022, 9 (1) e000657; DOI: 10.1136/lupus-2022-000657
Pregnancy outcomes in antiphospholipid antibody positive patients: prospective results from the AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) Clinical Database and Repository (‘Registry’)
Zeynep Belce Erton, Ecem Sevim, Guilherme Ramires de Jesús, Ricard Cervera, Lanlan Ji, Vittorio Pengo, Amaia Ugarte, Danieli Andrade, Laura Andreoli, Tatsuya Atsumi, Paul R Fortin, Maria Gerosa, Yu Zuo, Michelle Petri, Savino Sciascia, Maria G Tektonidou, Maria Angeles Aguirre- Zamorano, D Ware Branch, Doruk Erkan

Lupus Science & Medicine Jun 2022, 9 (1) e000633; DOI: 10.1136/lupus-2021-000633
Antibodies to FXa and thrombin in patients with SLE differentially regulate C3 and C5 cleavage
Thomas McDonnell, Raj Amarnani, Carina Spicer, Hajar Jbari, Charis Pericleous, Valentina A Spiteri, Chris Wincup, Bahar Artim-Esen, Ian Mackie, Marina Botto, Anisur Rahman, Ian Giles

Lupus Science & Medicine Aug 2022, 9 (1) e000738; DOI: 10.1136/lupus-2022-000738
Could severe COVID-19 be considered a complementopathy?
Katerina Chatzidionysiou, Elisabet Svenungsson, Francesca Faustini

Lupus Science & Medicine May 2020, 7 (1) e000415; DOI: 10.1136/lupus-2020-000415

Log in using your username and password

Main menu

Log in using your username and password

You are here

antibodies, antiphospholipid